NASDAQ:APOP Cellect Biotechnology (APOP) Stock Price, News & Analysis → The Single Biggest Breakthrough of the Decade (From Porter & Company) (Ad) Free APOP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$13.10▼$13.3750-Day Range$7.54▼$13.4052-Week Range$6.64▼$35.52Volume17,400 shsAverage Volume479,845 shsMarket Capitalization$12.87 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cellect Biotechnology alerts: Email Address Ad Porter & CompanyHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. About Cellect Biotechnology Stock (NASDAQ:APOP)Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.Read More Ad Porter & CompanyHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. APOP Stock News HeadlinesMarch 1, 2024 | wsj.comKrystal Biotech Inc.June 23, 2023 | bizjournals.comRaleigh/Durham Biotech NewsApril 19, 2023 | seekingalpha.comSana Biotechnology Is Technically Overbought So Buy It LaterApril 19, 2023 | cnbc.comPiper Sandler says this biotech stock can outperform thanks to Alzheimer's treatmentFebruary 23, 2023 | benzinga.com$3M Bet On This Biotechnology Stock? Check Out These 3 Penny Stocks Insiders Are BuyingJanuary 30, 2023 | finance.yahoo.comGlobal Agricultural Biotechnology Market to Reach $88.9 Billion by 2030November 24, 2022 | morningstar.comWhy These Biotech Stocks Are Outperforming the MarketNovember 16, 2022 | realmoney.thestreet.comSeeing Good Action in Biotechnology StocksSeptember 18, 2022 | fool.co.ukInvesting in Biotech: Top UK Biotech Stocks in 2022November 4, 2021 | finance.yahoo.comQuoin Pharmaceuticals Appoints Gordon Dunn as Chief Financial OfficerNovember 2, 2021 | finance.yahoo.comQuoin Pharmaceuticals Announces Signing of Exclusive License from Queensland University of Technology, AustraliaOctober 16, 2021 | apnews.comCellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with ...October 15, 2021 | finance.yahoo.comCellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Quoin PharmaceuticalsOctober 14, 2021 | finanznachrichten.deCellect Biotechnology Ltd.: Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin PharmaceuticalsSeptember 27, 2021 | benzinga.comWhy Cellect Biotechnology Shares Are Rising TodaySeptember 27, 2021 | finance.yahoo.comCellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin PharmaceuticalsSeptember 3, 2021 | markets.businessinsider.comPre-market Movers: APOP, FBRX, ANY, AGIL, ADXS…September 2, 2021 | finance.yahoo.comCellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in U.S.August 24, 2021 | finance.yahoo.comCellect Biotechnology Reports Second Quarter 2021 Financial and Operating ResultsAugust 13, 2021 | apnews.comThe Securities and Exchange Commission Declared Cellect Biotechnology’s Registration Statement ...August 13, 2021 | finance.yahoo.comThe Securities and Exchange Commission Declared Cellect Biotechnology’s Registration Statement Filed on Form F-4 Effective in Connection with its Previously Announced Strategic Merger with Quoin PharmaceuticalsJuly 27, 2021 | nasdaq.comCellect Biotechnology Ltd. American Depositary Shares (APOP)See More Headlines Receive APOP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cellect Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/13/2018Today6/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & Medical Instruments Sub-IndustryN/A Current SymbolNASDAQ:APOP CUSIPN/A CIK1671502 Webwww.cellect.co Phone(729) 974-1444Fax972-9767-8750Employees2,020Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio3.01 Quick Ratio3.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$4.77 per share Price / Book2.76Miscellaneous Outstanding Shares977,000Free FloatN/AMarket Cap$12.87 million OptionableNot Optionable Beta1.87 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesShai YarkoniChief Executive Officer & DirectorAmos OferChief Operating OfficerYaron Ben-OzChief Financial OfficerKey CompetitorsCytosorbentsNASDAQ:CTSOCo-DiagnosticsNASDAQ:CODXCarmellNASDAQ:CTCXBeyond AirNASDAQ:XAIRDaxorNASDAQ:DXRView All Competitors APOP Stock Analysis - Frequently Asked Questions How were Cellect Biotechnology's earnings last quarter? Cellect Biotechnology Ltd. (NASDAQ:APOP) announced its quarterly earnings data on Tuesday, November, 13th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.56) by $0.02. When did Cellect Biotechnology's stock split? Cellect Biotechnology's stock split on the morning of Tuesday, October 26th 2021. The 2-1 split was announced on Tuesday, October 26th 2021. The newly created shares were issued to shareholders after the market closes on Tuesday, October 26th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. What other stocks do shareholders of Cellect Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cellect Biotechnology investors own include Elbit Systems (ESLT), Gilead Sciences (GILD), Pluristem Therapeutics (PSTI), NVIDIA (NVDA), Teva Pharmaceutical Industries (TEVA), Acasti Pharma (ACST), Allergan (AGN), Novavax (NVAX) and RedHill Biopharma (RDHL). This page (NASDAQ:APOP) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | SponsoredElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine...InvestorPlace | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredLike Investing in Big Tech in the Early 2000s?More than a decade after the first Bitcoin was mined, people are finally realizing something very important......Manward Press | SponsoredThe Single Biggest Breakthrough of the Decade Billionaires, Jeff Bezos, Bill Gates, Warren Buffett, and Sir Richard Branson are rallying behind this technol...Porter & Company | SponsoredAn utter travestyThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellect Biotechnology Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellect Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.